CTNM
Contineum Therapeutics, Inc.
12.50$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | 38.7% | – | – | |
| – | – | 0.4% | – | – | |
| – | – | 4.4% | – | – | |
| – | – | -2.0% | – | – | |
| – | – | 0.8% | – | – | |
| – | – | -131.1% | – | – | |
| – | – | -0.1% | – | – | |
| – | – | -7.5% | – | – | |
| – | – | 112.4% | – | – | |
| – | – | 19.9% | – | – | |
| – | – | 37.9% | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.